Payment overview · 2025
General Payments
$109.49
1 reported records · 1 companies
Healthcare provider profile · identity verified
Stephen Kaplan, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · PLYMOUTH, MA · NPI 1629236849
Verified facts
What the public records show
CMS Open Payments records show Stephen Kaplan, M.D. received $109.49 in general payments during 2025 across 1 reported records.
Teva Pharmaceuticals USA, Inc. accounted for 100.0% of that reported general-payment amount.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $109.49 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Education | $109.49 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
Payment records were found, but the reported records did not identify a specific associated product for this analysis.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1202 | 365 |
| Amlodipine Besylate | Amlodipine Besylate | 683 | 196 |
| Lisinopril | Lisinopril | 657 | 187 |
| Levothyroxine Sodium | Levothyroxine Sodium | 542 | 132 |
| Omeprazole | Omeprazole | 455 | 136 |
| Losartan Potassium | Losartan Potassium | 445 | 137 |
| Simvastatin | Simvastatin | 415 | 104 |
| Metoprolol Succinate | Metoprolol Succinate | 400 | 117 |
| Hydrochlorothiazide | Hydrochlorothiazide | 388 | 122 |
| Gabapentin | Gabapentin | 386 | 85 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 341 | 110 |
| Trazodone Hcl | Trazodone Hcl | 301 | 78 |
| Oxycodone Hcl | Oxycodone Hcl | 276 | 36 |
| Lorazepam | Lorazepam | 247 | 54 |
| Duloxetine Hcl | Duloxetine Hcl | 224 | 54 |
| Furosemide | Furosemide | 222 | 61 |
| Tamsulosin Hcl | Tamsulosin Hcl | 218 | 64 |
| Eliquis | Apixaban | 216 | 52 |
| Pantoprazole Sodium | Pantoprazole Sodium | 202 | 63 |
| Valsartan | Valsartan | 192 | 51 |
| Metformin Hcl Er | Metformin Hcl | 191 | 60 |
| Metformin Hcl | Metformin Hcl | 183 | 55 |
| Allopurinol | Allopurinol | 182 | 54 |
| Pravastatin Sodium | Pravastatin Sodium | 176 | 56 |
| Atenolol | Atenolol | 169 | 46 |
| Sertraline Hcl | Sertraline Hcl | 169 | 42 |
| Jardiance | Empagliflozin | 161 | 40 |
| Escitalopram Oxalate | Escitalopram Oxalate | 140 | 38 |
| Spironolactone | Spironolactone | 139 | 38 |
| Potassium Chloride | Potassium Chloride | 138 | 33 |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 129 | 129 |
| Tramadol Hcl | Tramadol Hcl | 129 | 25 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 121 | 62 |
| Alprazolam | Alprazolam | 119 | 22 |
| Clonazepam | Clonazepam | 118 | 18 |
| Mirtazapine | Mirtazapine | 116 | 32 |
| Alendronate Sodium | Alendronate Sodium | 112 | 37 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 111 | 111 |
| Synthroid | Levothyroxine Sodium | 111 | 29 |
| Clopidogrel | Clopidogrel Bisulfate | 106 | 27 |
| Famotidine | Famotidine | 104 | 32 |
| Ozempic | Semaglutide | 100 | 19 |
| Zolpidem Tartrate | Zolpidem Tartrate | 98 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 95 | 25 |
| Incruse Ellipta | Umeclidinium Bromide | 93 | 20 |
| Metoprolol Tartrate | Metoprolol Tartrate | 90 | 30 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 89 | 19 |
| Warfarin Sodium | Warfarin Sodium | 87 | 26 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 83 | 24 |
| Pregabalin | Pregabalin | 82 | 15 |
| Diclofenac Sodium | Diclofenac Sodium | 80 | 28 |
| Nifedipine Er | Nifedipine | 76 | 24 |
| Diazepam | Diazepam | 74 | 16 |
| Prednisone | Prednisone | 73 | 59 |
| Lovastatin | Lovastatin | 72 | 21 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 71 | 14 |
| Mounjaro | Tirzepatide | 71 | 14 |
| Fluticasone Propionate | Fluticasone Propionate | 70 | 33 |
| Propranolol Hcl | Propranolol Hcl | 69 | 23 |
| Glipizide | Glipizide | 67 | 20 |
| Fluoxetine Hcl | Fluoxetine Hcl | 66 | 22 |
| Glimepiride | Glimepiride | 59 | 19 |
| Morphine Sulfate Er | Morphine Sulfate | 59 | suppressed |
| Celecoxib | Celecoxib | 57 | 16 |
| Tizanidine Hcl | Tizanidine Hcl | 57 | 17 |
| Trulicity | Dulaglutide | 56 | 15 |
| Buspirone Hcl | Buspirone Hcl | 55 | 13 |
| Carvedilol | Carvedilol | 55 | 17 |
| Ibuprofen | Ibuprofen | 55 | 20 |
| Oxycontin | Oxycodone Hcl | 54 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 52 | 16 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 52 | 28 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 51 | 40 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 49 | suppressed |
| Ketoconazole | Ketoconazole | 49 | 21 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 49 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 48 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 47 | suppressed |
| Januvia | Sitagliptin Phosphate | 46 | 15 |
| Montelukast Sodium | Montelukast Sodium | 46 | 16 |
| Azelastine Hcl | Azelastine Hcl | 44 | 19 |
| Rybelsus | Semaglutide | 44 | suppressed |
| Klor-Con M20 | Potassium Chloride | 43 | 15 |
| Estradiol | Estradiol | 42 | 13 |
| Donepezil Hcl | Donepezil Hcl | 41 | suppressed |
| Bupropion Xl | Bupropion Hcl | 40 | suppressed |
| Ezetimibe | Ezetimibe | 40 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 40 | 14 |
| Arnuity Ellipta | Fluticasone Furoate | 39 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 39 | 26 |
| Chlorthalidone | Chlorthalidone | 37 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 37 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 36 | 15 |
| Paroxetine Hcl | Paroxetine Hcl | 35 | suppressed |
| Topiramate | Topiramate | 35 | 11 |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 34 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 34 | 13 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 34 | 29 |
| Levetiracetam | Levetiracetam | 32 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 32 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 31 | suppressed |
| Myrbetriq | Mirabegron | 30 | 11 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 29 | suppressed |
| Primidone | Primidone | 29 | suppressed |
| Xarelto | Rivaroxaban | 29 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 28 | 26 |
| Clonidine Hcl | Clonidine Hcl | 28 | suppressed |
| Dulera | Mometasone/Formoterol | 28 | suppressed |
| Eszopiclone | Eszopiclone | 28 | suppressed |
| Torsemide | Torsemide | 28 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 27 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 26 | suppressed |
| Glipizide Er | Glipizide | 26 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 25 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 25 | suppressed |
| Finasteride | Finasteride | 24 | suppressed |
| Meloxicam | Meloxicam | 24 | suppressed |
| Ibu | Ibuprofen | 23 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 22 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 22 | suppressed |
| Aripiprazole | Aripiprazole | 21 | suppressed |
| Colchicine | Colchicine | 21 | 13 |
| Nystatin | Nystatin | 21 | suppressed |
| Scopolamine | Scopolamine | 21 | suppressed |
| Verapamil Er | Verapamil Hcl | 21 | suppressed |
| Cilostazol | Cilostazol | 20 | suppressed |
| Hydrocortisone | Hydrocortisone | 20 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 20 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 20 | 13 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 19 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 19 | suppressed |
| Cephalexin | Cephalexin | 19 | 15 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 19 | suppressed |
| Baclofen | Baclofen | 18 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 18 | suppressed |
| Jantoven | Warfarin Sodium | 17 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 17 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 17 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 16 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 16 | suppressed |
| Lactulose | Lactulose | 16 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 16 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 16 | 16 |
| Amantadine | Amantadine Hcl | 15 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 15 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 15 | suppressed |
| Nabumetone | Nabumetone | 15 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 15 | suppressed |
| Acyclovir | Acyclovir | 14 | suppressed |
| Fluconazole | Fluconazole | 14 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 14 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 14 | suppressed |
| Nitroglycerin | Nitroglycerin | 14 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 14 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 14 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 14 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 13 | suppressed |
| Enulose | Lactulose | 13 | suppressed |
| Epinephrine | Epinephrine | 13 | 11 |
| Farxiga | Dapagliflozin Propanediol | 13 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 13 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 13 | suppressed |
| Guanfacine Hcl | Guanfacine Hcl | 13 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 13 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 12 | suppressed |
| Azithromycin | Azithromycin | 12 | 12 |
| Calcitriol | Calcitriol | 12 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 12 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 12 | suppressed |
| Risperidone | Risperidone | 12 | suppressed |
| Trospium Chloride | Trospium Chloride | 12 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 12 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Digoxin | Digoxin | 11 | suppressed |
| Estradiol (Twice Weekly) | Estradiol | 11 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 11 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 11 | suppressed |
| Methylphenidate Er | Methylphenidate Hcl | 11 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 11 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 11 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 11 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 11 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 11 | suppressed |
| Veozah | Fezolinetant | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $109.49 · 1 records | Teva Pharmaceuticals USA, Inc. | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error